Bangladesh could be the first to cultivate golden rice, genetically altered to fight blindness
Approval expected for the rice, long a flashpoint in debates over GM crops
Health
-
-
New polymer-coated vitamins and minerals could fight malnutrition in low-income countries
Encapsulating nutrients protects them from degradation -
Toxic gut bacteria make alcohol-triggered liver disease more deadly
Research team reduced liver disease in mice by killing bacterium with viruses found in sewer -
Revamped cancer drug starves tumors in mice
Compound that robs tumors of essential amino acid headed for clinical trials -
New dengue vaccine performs well in large trial, but safety remains key concern
Peculiar biology of four viral strains complicate immunization attempts -
Texas voters approve second life for state cancer funding agency
Supporters say CPRIT has been boon for research efforts and state economy -
Alzheimer’s experts greet China’s surprise approval of a drug for brain disease with hope and caution
With an active ingredient derived from brown algae, the medication appears to alter the gut microbiome and reduce inflammation in the brain -
Colombian woman’s genes offer new clues to staving off Alzheimer’s
A rare mutation in a known Alzheimer’s risk gene points to potential treatments -
New technologies promise sharper artificial vision for blind people
Researchers hone techniques to restore sight by stimulating the retina or brain -
How measles causes the body to ‘forget’ past infections by other microbes
With measles cases rising around the world, studies showing it causes immune amnesia underscore the importance of widespread vaccination -
A powerful tuberculosis drug gets a deep price cut
Rifapentine could prevent disease in millions of people -
Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments
Strategy appears to block KRAS tumor growth protein -
NIH and Gates Foundation lay out ambitious plan to bring gene-based treatments for HIV and sickle cell disease to Africa
$200 million collaboration aims to launch gene therapy and editing clinical trials within a decade -
New drug forces flu virus into ‘error catastrophe,’ overwhelming it with mutations
Human trials are likely to start next spring -
Four new drugs may help fight the growing threat of fatal fungi
Well-stocked pipeline could give doctors new tools against intractable infections -
Alzheimer’s drug resurrected, as company claims clinical benefits
Further analysis of trial data, particularly from people on higher doses of antibody, persuaded Biogen that its drug slows patients’ decline
